Cost-Utility analysis of a telehealth programme for patients with severe chronic obstructive pulmonary disease treated with Long-Term oxygen therapy

Journal of Telemedicine and Telecare

Volumn 20, Issue 6, 2014, Pages 307-316

  Jódar Sánchez, Francisco ^a,b   Ortega, Francisco ^a   Calderón, Carlos Parra ^a   Gómez Suárez, Cristina ^c   Bonachela, Patricia ^a   Leal, Sandra ^a,b   Pérez, Pablo ^a   Jordán, Ana ^c   Barrot, Emilia ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b Andalusian Public Foundation for the Management of Health Research   (Spain)

^c Linde Healthcare   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OXYGEN THERAPY; PILOT STUDY; PROGRAM EVALUATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; TELEMEDICINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); OXYGEN INHALATION THERAPY; PILOT PROJECTS; PROGRAM EVALUATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY-ADJUSTED LIFE YEARS; TELEMEDICINE;

EID: 84924760447     PISSN: 1357633X     EISSN: 17581109     Source Type: Journal    
DOI: 10.1177/1357633X14544421     Document Type: Article

References (37)

1. Ancochea J, Badiola C, Duran-Tauleria E, et al. The EPISCAN survey to assess the prevalence of chronic obstructive pulmonary disease in Spanish 40-to-80-year-olds: protocol summary. Arch Bronconeumol 2009;45:41-7. [Spanish].
2. Masa JF, Sobradillo V, Villasante C, et al. Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study. Arch Bronconeumol 2004;40:72-9. [Spanish].
3. García Ruiz AJ, Leiva Fernández F, Martos Crespo F, et al. COPD-related use of resources and direct health costs in primary care (COPD-PC study). Rev Esp Econ Salud 2003;2:176-181. [Spanish].
4. Miravitlles M, Murio C, Guerrero T, Gisbert R. Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest 2003;123:784-91.
5. Toy EL, Gallagher KF, Stanley EL, Swensen AR, Duh MS. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD 2010;7:214-28.
6. Bolton CE, Waters CS, Peirce S, et al. Insufficient evidence of benefit: a systematic review of home telemonitoring for COPD. J Eval Clin Pract 2011;17:1216-22.
7. Jaana M, Paré G, Sicotte C. Home telemonitoring for respiratory conditions: a systematic review. Am J Manag Care 2009;15:313-20.
8. McLean S, Nurmatov U, Liu JL, Pagliari C, Car J, Sheikh A. Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011;7:CD007718.
9. Polisena J, Tran K, Cimon K, et al. Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Telemed Telecare 2010;16:120-7.
10. Mistry H. Systematic review of studies of the cost-effectiveness of telemedicine and telecare. Changes in the economic evidence over twenty years. J Telemed Telecare 2012;18:1-6.
11. Whitten PS, Mair FS, Haycox A, May CR, Williams TL, Hellmich S. Systematic review of cost effectiveness studies of telemedicine interventions. BMJ 2002;324:1434-7.
12. Wootton R. Twenty years of telemedicine in chronic disease management - an evidence synthesis. J Telemed Telecare 2012;18:211-20.
13. Jódar-Sánchez F, Ortega F, Parra C, et al. Implementation of a telehealth programme for patients with severe chronic obstructive pulmonary disease treated with long-term oxygen therapy. J Telemed Telecare 2013;19:11-7.
14. López Bastida J, Oliva J, Antoñanzas F, et al. A proposed guideline for economic evaluation of health technologies. Gac Sanit 2010;24:154-70. [Spanish].
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
16. National Statistics Institute. Spanish Consumer Price Index. See http://www.ine.es/en/inebmenu/mnu_nivel_vida_en.htm (last checked 28 May 2014).
17. Government of Andalusia. Order of 14 October 2005, which are priced public health services provided by centers dependent of Andalusian Public Health System. See http://juntadeandalucia. es/boja/2005/210/d28.pdf [Spanish] (last checked 9 June 2014).
18. Ministry of Health,Social Services and Equality. Analysis and development of the GRDs in the National Health System. Year 2010. See http://www.msssi.gob.es/estadEstudios/ estadisticas/inforRecopilaciones/anaDesarrolloGDR.htm [Spanish] (last checked 28 May 2014).
19. Andalusian Health Service. Resolution 0296/11 of October 28. See http://www.juntadeandalucia.es/servicioandaluzdesalud/ library/plantillas/externa.asp?pag=/contenidos/profesionales/ normativas/R0296_2011/R0296_11.pdf [Spanish] (last checked 11 June 2014).
20. Linde Healthcare. See http://www.linde-healthcare.es/es/ index.html [Spanish] (last checked 28 May 2014).
21. Drummond MF, Sculpher MJ, Torrance GW, O'Brien B, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. 3rd edn. Oxford: Oxford University Press, 2005.
22. Badia X, Roset M, Montserrat S, Herdman M, Segura A. The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Med Clin (Barc) 1999;112(Suppl. 1): 79-85. [Spanish].
23. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A selfcomplete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
24. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005;14:487-96.
25. Briggs AH, Wonderling DE, Mooney CZ. Pulling costeffectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6:327-40.
26. Black WC. The CE plane: a graphic representation of costeffectiveness. Med Decis Making 1990;10:212-4.
27. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Econ 2004;13:405-15.
28. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:549-55.
29. Sacristán JA, Oliva J, Del Llano J, Prieto L, Pinto JL. What is an efficient health technology in Spain? Gac Sanit 2002;16:334-43. [Spanish].
30. Paré G, Sicotte C, St-Jules D, Gauthier R. Cost-minimization analysis of a telehomecare program for patients with chronic obstructive pulmonary disease. Telemed J E Health 2006;12:114-21.
31. Henderson C, Knapp M, Fernández JL, et al. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial. BMJ 2013;346:f1035.
32. Bayón Yusta JC, Orruño Aguado E, Asua Batarrita J, Artetxe Ocasar J, Emparanza Knör JI, Gorostiza Hormaetxe I. Cost-effectiveness analysis of a telemonitoring experiment in patients with cardiac insufficiency and chronic obstructive pulmonary disease. Office for Health Technology Assessment (Osteba), Vitoria-Gasteiz, Spain. See http://www9.euskadi.net/sanidad/osteba/datos/Analisis %20coste.pdf [Spanish] (last checked 28 May 2014).
33. Koff PB, Jones RH, Cashman JM, Voelkel NF, Vandivier RW. Proactive integrated care improves quality of life in patients with COPD. Eur Respir J 2009;33:1031-8.
34. Vitacca M, Bianchi L, Guerra A, et al. Tele-assistance in chronic respiratory failure patients: a randomised clinical trial. Eur Respir J 2009;33:411-8.
35. Bustacchini S, Chiatti C, Furneri G, Lattanzio F, Mantovani LG. The economic burden of chronic obstructive pulmonary disease in the elderly: results from a systematic review of the literature. Curr Opin Pulm Med 2011;17(Suppl. 1): S35-41.
36. Smith SM, Elkin SL, Partridge MR. Technology and its role in respiratory care. Prim Care Respir J 2009;18:159-64.
37. Commission of the European Communities. Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on telemedicine for the benefit of patients, healthcare systems and society. See http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=COM:2008:0689:FIN:EN:PDF (last checked 28 May 2014).